Haemonetics Stock Forecast

Stock Price Forecast

The 7 analysts with 12-month price forecasts for Haemonetics stock have an average target of 76.71, with a low estimate of 62 and a high estimate of 89. The average target predicts a decrease of -0.75% from the current stock price of 77.29.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$62	$76.71	$80	$89
Change	-19.78%	-0.75%	+3.51%	+15.15%

Analyst Ratings

The average analyst rating for Haemonetics stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	3	3	3	3	4	4
Buy	4	4	4	4	4	4
Hold	4	4	4	4	3	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	11	11	11	11	11	11

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Marie Thibault BTIG	BTIG	Buy Reiterates $84	Buy	Reiterates	$84	+8.68%	Jun 26, 2026
Anthony Petrone Mizuho Securities	Mizuho Securities	Buy Maintains $70 → $85	Buy	Maintains	$70 → $85	+9.98%	Jun 15, 2026
Travis Steed Bank of America Securities	Bank of America Securities	Buy Maintains $80	Buy	Maintains	$80	+3.51%	Jun 5, 2026
Joanne Wuensch Citi	Citi	Hold Maintains $64 → $70	Hold	Maintains	$64 → $70	-9.43%	May 28, 2026
Michael Petusky Barrington	Barrington	Buy Maintains $94 → $89	Buy	Maintains	$94 → $89	+15.15%	May 12, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

1.40B

from 1.33B

4.98%

from 1.33B

Revenue Next Year

1.47B

from 1.40B

5.27%

from 1.40B

EPS This Year

5.22

from 4.96

5.23%

from 4.96

EPS Next Year

5.76

from 5.22

10.34%

from 5.22

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028
Period Ending	Apr 2, 2022	Apr 1, 2023	Mar 30, 2024	Mar 29, 2025	Mar 28, 2026	Mar 31, 2027	Mar 31, 2028
Revenue	993.20M	1.17B	1.31B	1.36B	1.33B	1.40B	1.47B
Revenue Growth	14.10%	17.67%	12.01%	3.96%	-1.97%	4.98%	5.27%
EPS	0.84	2.24	2.29	3.31	2.05	3.94	4.47
EPS Growth	-45.81%	166.67%	2.23%	44.54%	-38.07%	92.36%	13.23%
Forward PE	-	-	-	-	-	19.60	17.31
No. Analysts	-	-	-	-	-	11	11

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2027	2028
High	1.4B	1.5B
Avg	1.4B	1.5B
Low	1.4B	1.4B

Revenue Growth

Revenue Growth	2027	2028
High	5.5%	7.1%
Avg	5.0%	5.3%
Low	4.1%	3.0%

EPS Forecast

EPS	2027	2028
High	5.26	6.11
Avg	5.22	5.76
Low	5.17	5.51

EPS Growth

EPS Growth	2027	2028
High	6.0%	17.0%
Avg	5.2%	10.3%
Low	4.2%	5.6%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.